Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Westside Medical
mi
from
Clinton, UT
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Westside Medical
mi
from
Clinton, UT
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
University of California at San Francisco
mi
from
San Francisco, CA
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Alexian Brothers Center for Psychiatric Research
mi
from
Hoffman Estates, IL
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Alexian Brothers Center for Psychiatric Research
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Louisiana State University Health Science Center
mi
from
Shreveport, LA
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Louisiana State University Health Science Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Oklahoma University Child Study Center
mi
from
Oklahoma City, OK
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Oklahoma University Child Study Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Hershey Medical Center
mi
from
Hershey, PA
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Drexel University
mi
from
Philadelphia, PA
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
The University of Texas, Houston
mi
from
Houston, TX
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
The University of Texas, Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated:  4/17/2018
Mount Sinai School of Medicine
mi
from
New York, NY
A Trial of CM-AT in Children With Autism
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Status: Enrolling
Updated: 4/17/2018
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated:  4/17/2018
Montefiore Medical Center
mi
from
Bronx, NY
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated: 4/17/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated:  4/17/2018
University of Cincinnati
mi
from
Cincinnati, OH
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated: 4/17/2018
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated:  4/17/2018
University of California at San Francisco
mi
from
San Francisco, CA
Stress Management Intervention for Living With Epilepsy (SMILE)
Pre-emptive Treatment in Epilepsy Using Electronic Diaries: Towards a New Frontier in Epilepsy Therapy
Status: Enrolling
Updated: 4/17/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Enhancing Written Communication in Persons With Aphasia
Enhancing Written Communication in Persons With Aphasia: A Clinical Trial
Status: Enrolling
Updated:  4/17/2018
Center for Aphasia Research & Treatment, Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Enhancing Written Communication in Persons With Aphasia
Enhancing Written Communication in Persons With Aphasia: A Clinical Trial
Status: Enrolling
Updated: 4/17/2018
Center for Aphasia Research & Treatment, Rehabilitation Institute of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Understanding Concussion/Mild Traumatic Brain Injury
Understanding Concussion/Mild Traumatic Brain Injury
Status: Enrolling
Updated:  4/17/2018
Johnson. C. Smith University
mi
from
Charlotte, NC
Understanding Concussion/Mild Traumatic Brain Injury
Understanding Concussion/Mild Traumatic Brain Injury
Status: Enrolling
Updated: 4/17/2018
Johnson. C. Smith University
mi
from
Charlotte, NC
Click here to add this to my saved trials
Understanding Concussion/Mild Traumatic Brain Injury
Understanding Concussion/Mild Traumatic Brain Injury
Status: Enrolling
Updated:  4/17/2018
Hershey Bears Ice Hockey Team
mi
from
Hershey, PA
Understanding Concussion/Mild Traumatic Brain Injury
Understanding Concussion/Mild Traumatic Brain Injury
Status: Enrolling
Updated: 4/17/2018
Hershey Bears Ice Hockey Team
mi
from
Hershey, PA
Click here to add this to my saved trials
Understanding Concussion/Mild Traumatic Brain Injury
Understanding Concussion/Mild Traumatic Brain Injury
Status: Enrolling
Updated:  4/17/2018
The Citadel
mi
from
Charleston, SC
Understanding Concussion/Mild Traumatic Brain Injury
Understanding Concussion/Mild Traumatic Brain Injury
Status: Enrolling
Updated: 4/17/2018
The Citadel
mi
from
Charleston, SC
Click here to add this to my saved trials
Understanding Concussion/Mild Traumatic Brain Injury
Understanding Concussion/Mild Traumatic Brain Injury
Status: Enrolling
Updated:  4/17/2018
South Carolina Stingrays
mi
from
North Charleston, SC
Understanding Concussion/Mild Traumatic Brain Injury
Understanding Concussion/Mild Traumatic Brain Injury
Status: Enrolling
Updated: 4/17/2018
South Carolina Stingrays
mi
from
North Charleston, SC
Click here to add this to my saved trials
Understanding Concussion/Mild Traumatic Brain Injury
Understanding Concussion/Mild Traumatic Brain Injury
Status: Enrolling
Updated:  4/17/2018
Spartinburg High School
mi
from
Spartanburg, SC
Understanding Concussion/Mild Traumatic Brain Injury
Understanding Concussion/Mild Traumatic Brain Injury
Status: Enrolling
Updated: 4/17/2018
Spartinburg High School
mi
from
Spartanburg, SC
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Austin Epilepsy Care Center
mi
from
Austin, TX
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Austin Epilepsy Care Center
mi
from
Austin, TX
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Bradenton Research Center
mi
from
Bradenton, FL
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Bradenton Research Center
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Clinical Trials, Inc.
mi
from
Little Rock, AR
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Clinical Trials, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Consultants in Epilepsy and Neurology, PLLC
mi
from
Boise, ID
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Consultants in Epilepsy and Neurology, PLLC
mi
from
Boise, ID
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Johns Hopkins University
mi
from
Baltimore, MD
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Josephson Wallack Munshower Neurology P.C
mi
from
Indianapolis, IN
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Josephson Wallack Munshower Neurology P.C
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Kaiser Permanente, Department of Neurology
mi
from
Anaheim, CA
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Kaiser Permanente, Department of Neurology
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Lovelace Scientific Resources
mi
from
Sarasota, FL
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Lovelace Scientific Resources
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Mid-Atlantic Epilepsy and Sleep Center
mi
from
Bethesda, MD
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Mid-Atlantic Epilepsy and Sleep Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Montefiore Medical Center
mi
from
Bronx, NY
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Neuro-Pain Medical Center
mi
from
Fresno, CA
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Neuro-Pain Medical Center
mi
from
Fresno, CA
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Neurological Clinic of Texas, P.A. Research
mi
from
Dallas, TX
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Neurological Clinic of Texas, P.A. Research
mi
from
Dallas, TX
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Neurology Clinic PC
mi
from
Waldorf, MD
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Neurology Clinic PC
mi
from
Waldorf, MD
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Neuroresearch II, Inc.
mi
from
Ventura, CA
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Neuroresearch II, Inc.
mi
from
Ventura, CA
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Neuroresearch, Inc. - Torrance
mi
from
Torrance, CA
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Neuroresearch, Inc. - Torrance
mi
from
Torrance, CA
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
NYU Comprehensive Epilepsy Center
mi
from
New York, NY
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
NYU Comprehensive Epilepsy Center
mi
from
New York, NY
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
St. Joseph's Hospital and Medical Center - Barrow Neurology Clinics
mi
from
Phoenix, AZ
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
St. Joseph's Hospital and Medical Center - Barrow Neurology Clinics
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
The Neurological Institute
mi
from
Charlotte, NC
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
The Neurological Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
University of Florida Health Sciences Center Jacksonville (Neurology Department)
mi
from
Jacksonville, FL
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
University of Florida Health Sciences Center Jacksonville (Neurology Department)
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
University of Kentucky Hospital
mi
from
Lexington, KY
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
University of Kentucky Hospital
mi
from
Lexington, KY
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
University of Toledo Health Science Campus
mi
from
Toledo, OH
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
University of Toledo Health Science Campus
mi
from
Toledo, OH
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
University of Virginia Comprehensive Epilepsy Program
mi
from
Charlottesville, VA
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
University of Virginia Comprehensive Epilepsy Program
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Vanderbilt Epilepsy Clinic
mi
from
Nashville, TN
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Vanderbilt Epilepsy Clinic
mi
from
Nashville, TN
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
West Los Angeles VA Medical Center, Clinical Research Center
mi
from
Los Angeles, CA
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
West Los Angeles VA Medical Center, Clinical Research Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
University of Cincinnati Physicians Company, LLC
mi
from
Cincinnati, OH
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
University of Cincinnati Physicians Company, LLC
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Ohio State University Medical Center
mi
from
Columbus, OH
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Strategic Health Evaluators
mi
from
Chatswood,
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Strategic Health Evaluators
mi
from
Chatswood,
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
The Comprehensive Epilepsy Care Center for Children and Adults
mi
from
Saint Louis, MO
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
The Comprehensive Epilepsy Care Center for Children and Adults
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated:  4/18/2018
Thomas Jefferson Comprehensive Epilepsy Center
mi
from
Philadelphia, PA
A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures, With Optional Open-Label Extension
Status: Enrolling
Updated: 4/18/2018
Thomas Jefferson Comprehensive Epilepsy Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
E-Selectin Nasal Instillation to Prevent Secondary Stroke
Induction of Mucosal Tolerance to Human E-Selectin for the Secondary Prevention of Stroke
Status: Enrolling
Updated:  4/21/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
E-Selectin Nasal Instillation to Prevent Secondary Stroke
Induction of Mucosal Tolerance to Human E-Selectin for the Secondary Prevention of Stroke
Status: Enrolling
Updated: 4/21/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
Status: Enrolling
Updated:  4/23/2018
Massachusetts General Hospital
mi
from
Boston, MA
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders
Status: Enrolling
Updated: 4/23/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials